title: Generator-based PET radiopharmaceuticals for molecular imaging of tumours: on the way to THERANOSTICS.
abstract: Generator-derived radionuclides for PET/CT imaging are promising for optimizing targeted radiotherapy by an individual patient-based approach, applying pre-therapeutic evaluation, as well as dosimetric calculations, and for measuring treatment response after radionuclide therapy.
authors: Institute of Nuclear Chemistry, Johannes Gutenberg University, Mainz, Germany. frank.roesch@uni-mainz.de
authors: Frank
authors: F
authors: Rösch
authors: Richard P
authors: RP
authors: Baum
mesh_terms: D056831:Coordination Complexes / Q000737:chemistry / Q000627:therapeutic use; D006573:Heterocyclic Compounds, 1-Ring / Q000737:chemistry; D006801:Humans; D008670:Metals / Q000737:chemistry; D009369:Neoplasms / Q000000981:diagnostic imaging* / Q000532:radiotherapy; D049268:Positron-Emission Tomography; D019275:Radiopharmaceuticals / Q000737:chemistry / Q000627:therapeutic use
chemical_list: D056831:Coordination Complexes; D006573:Heterocyclic Compounds, 1-Ring; D008670:Metals; D019275:Radiopharmaceuticals; C071349:1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acid